Yıl: 2021 Cilt: 43 Sayı: 1 Sayfa Aralığı: 20 - 25 Metin Dili: İngilizce DOI: 10.14744/etd.2020.65625 İndeks Tarihi: 27-01-2022

Serum Level of ADAMTS4 and ADAMTS8 in Patientswith Psoriatic Arthritis

Öz:
Objective: Psoriatic arthritis (PsA) is a chronic inflammatory disease associated with psoriasis. A disintegrin and metallopro teinase with thrombospondin motifs (ADAMTS) is a large family of proteoglycanase enzymes that show proteolytic activity.The expression levels of ADAMTS proteases in osteoarthritis and rheumatoid arthritis are upregulated. However, theirexpression levels in PsA patients have not been examined yet. The aim of this study was to determine the serum levels ofADAMTS4 and ADAMTS8 in PsA patients. Materials and Methods: This was a case-control study and enrolled 40 PsA patients and 40 individuals as controls. Serumlevels of ADAMTS4 and ADAMTS8 were examined by the enzyme-linked immunosorbent assay (ELISA). The relationshipbetween ADAMTS8 levels and demographic and clinical features of PsA patients were analyzed. Results: The results of this study showed that the ADAMTS8 level was significantly elevated in the serum of PsA patients(160.9±49.79 pg/mL) compared to the control groups (<15.6 pg/mL). An association (r=0.32, p<0.05) was detected betweenage and serum level of ADAMTS8. However, the level of the ADAMTS4 in many subjects was under the detectable range. Conclusion: Our results conclude that a relationship exists between ADAMTS8 and PsA, but further investigations arerequired to establish the function of ADAMTS8 proteases in PsA.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. Nestle FO, Kaplan DH, Barker J. Psoriasis. N Engl J Med 2009; 361(5): 496–509.
  • 2. Lønnberg AS, Skov L. Co-morbidity in psoriasis: mechanisms and implications for treatment. Expert Rev Clin Immunol 2017; 13(1): 27–34.
  • 3. Mathew AJ, Chandran V. Depression in Psoriatic Arthritis: Dimensional Aspects and Link with Systemic Inflammation. Rheumatol Ther 2020; 7(2): 287–300.
  • 4. Lorenzo A, Pardo E, Charca L, Pino M, Queiro R. Enthesitis and joint erosions are disease traits associated with cardiovascular risk in psoriatic arthritis. Clin Rheumatol 2020; 39(10): 2973–9.
  • 5. Gottlieb A, Merola JF. Psoriatic arthritis for dermatologists. J Dermatolog Treat 2020; 31(7): 662–79.
  • 6. Gottlieb AB, Mease PJ, Mark Jackson J, Eisen D, Amy Xia H, Asare C, et al. Clinical characteristics of psoriatic arthritis and psoriasis in dermatologists’ offices. J Dermatolog Treat 2006; 17(5): 279–87.
  • 7. Rida MA, Chandran V. Challenges in the clinical diagnosis of psoriatic arthritis. Clin Immunol 2020;214: 108390.
  • 8. Stanton H, Melrose J, Little CB, Fosang AJ. Proteoglycan degradation by the ADAMTS family of proteinases. Biochim Biophys Acta 2011; 1812(12): 1616–29.
  • 9. Salter RC, Ashlin TG, Kwan AP, Ramji DP. ADAMTS proteases: key roles in atherosclerosis?. J Mol Med (Berl) 2010; 88(12): 1203–11.
  • 10. Wågsäter D, Björk H, Zhu C, Björkegren J, Valen G, Hamsten A, et al. ADAMTS-4 and -8 are inflammatory regulated enzymes expressed in macrophage-rich areas of human atherosclerotic plaques. Atherosclerosis 2008; 196(2): 514–22.
  • 11. Botter SM, Glasson SS, Hopkins B, Clockaerts S, Weinans H, van Leeuwen JP, et al. ADAMTS5-/- mice have less subchondral bone changes after induction of osteoarthritis through surgical instability: implications for a link between cartilage and subchondral bone changes. Osteoarthritis Cartilage 2009; 17(5): 636–45.
  • 12. Bondeson J, Wainwright S, Hughes C, Caterson B. The regulation of the ADAMTS4 and ADAMTS5 aggrecanases in osteoarthritis: a review. Clin Exp Rheumatol 2008; 26(1): 139–45.
  • 13. Malfait AM, Liu RQ, Ijiri K, Komiya S, Tortorella MD. Inhibition of ADAM-TS4 and ADAM-TS5 prevents aggrecan degradation in osteoarthritic cartilage. J Biol Chem 2002; 277(25): 22201–8.
  • 14. Helliwell PS, Taylor WJ. Classification and diagnostic criteria for psoriatic arthritis. Ann Rheum Dis 2005; 64(Suppl 2): ii3–8.
  • 15. Fransen J, Creemers MC, Van Riel PL. Remission in rheumatoid arthritis: agreement of the disease activity score (DAS28) with the ARA preliminary remission criteria. Rheumatology (Oxford) 2004; 43(10): 1252–5.
  • 16. Kelwick R, Desanlis I, Wheeler GN, Edwards DR. The ADAMTS (A Disintegrin and Metalloproteinase with Thrombospondin motifs) family. Genome Biol 2015; 16(1): 113.
  • 17. Lin EA, Liu CJ. The role of ADAMTSs in arthritis. Protein Cell 2010; 1(1): 33–47.
  • 18. Cal S, López-Otín C. ADAMTS proteases and cancer. Matrix Biol 2015; 44-46: 77–85.
  • 19. Mimata Y, Kamataki A, Oikawa S, Murakami K, Uzuki M, Shimamura T, et al. Interleukin-6 upregulates expression of ADAMTS-4 in fibroblast-like synoviocytes from patients with rheumatoid arthritis. Int J Rheum Dis 2012; 15(1): 36–44.
  • 20. Song RH, Tortorella MD, Malfait AM, Alston JT, Yang Z, Arner EC, et al. Aggrecan degradation in human articular cartilage explants is mediated by both ADAMTS-4 and ADAMTS-5. Arthritis Rheum 2007; 56(2): 575–85
  • 21. Ayanoglu T, Atalar H, Esen E, Ataoğlu MB, Turanlı S, Demircan K. The role of ADAMTS genes in the end stage of hip osteoarthritis. Acta Orthop Traumatol Turc 2019; 53(2): 140–4.
  • 22. Collins-Racie LA, Flannery CR, Zeng W, Corcoran C, Annis-Freeman B, Agostino MJ, et al. ADAMTS-8 exhibits aggrecanase activity and is expressed in human articular cartilage. Matrix Biol 2004; 23(4): 219–30.
  • 23. Davidson RK, Waters JG, Kevorkian L, Darrah C, Cooper A, DonellST, et al. Expression profiling of metalloproteinases and their inhibitors in synovium and cartilage. Arthritis Res Ther 2006; 8(4): R124.
  • 24. Peluso R, Caso F, Tasso M, Sabbatino V, Lupoli R, Dario Di Minno MN, et al. Biomarkers of subclinical atherosclerosis in patients with psoriatic arthritis. Open Access Rheumatol 2019; 11: 143–56.
  • 25. Veale DJ, Fearon U. The pathogenesis of psoriatic arthritis. Lancet 2018; 391(10136): 2273–84
APA Icen Taskin I, İRTEGÜN KANDEMİR S, NAS K, Dağlı A (2021). Serum Level of ADAMTS4 and ADAMTS8 in Patientswith Psoriatic Arthritis. , 20 - 25. 10.14744/etd.2020.65625
Chicago Icen Taskin Irmak,İRTEGÜN KANDEMİR Sevgi,NAS Kemal,Dağlı Abdullah Zübeyir Serum Level of ADAMTS4 and ADAMTS8 in Patientswith Psoriatic Arthritis. (2021): 20 - 25. 10.14744/etd.2020.65625
MLA Icen Taskin Irmak,İRTEGÜN KANDEMİR Sevgi,NAS Kemal,Dağlı Abdullah Zübeyir Serum Level of ADAMTS4 and ADAMTS8 in Patientswith Psoriatic Arthritis. , 2021, ss.20 - 25. 10.14744/etd.2020.65625
AMA Icen Taskin I,İRTEGÜN KANDEMİR S,NAS K,Dağlı A Serum Level of ADAMTS4 and ADAMTS8 in Patientswith Psoriatic Arthritis. . 2021; 20 - 25. 10.14744/etd.2020.65625
Vancouver Icen Taskin I,İRTEGÜN KANDEMİR S,NAS K,Dağlı A Serum Level of ADAMTS4 and ADAMTS8 in Patientswith Psoriatic Arthritis. . 2021; 20 - 25. 10.14744/etd.2020.65625
IEEE Icen Taskin I,İRTEGÜN KANDEMİR S,NAS K,Dağlı A "Serum Level of ADAMTS4 and ADAMTS8 in Patientswith Psoriatic Arthritis." , ss.20 - 25, 2021. 10.14744/etd.2020.65625
ISNAD Icen Taskin, Irmak vd. "Serum Level of ADAMTS4 and ADAMTS8 in Patientswith Psoriatic Arthritis". (2021), 20-25. https://doi.org/10.14744/etd.2020.65625
APA Icen Taskin I, İRTEGÜN KANDEMİR S, NAS K, Dağlı A (2021). Serum Level of ADAMTS4 and ADAMTS8 in Patientswith Psoriatic Arthritis. Erciyes Medical Journal, 43(1), 20 - 25. 10.14744/etd.2020.65625
Chicago Icen Taskin Irmak,İRTEGÜN KANDEMİR Sevgi,NAS Kemal,Dağlı Abdullah Zübeyir Serum Level of ADAMTS4 and ADAMTS8 in Patientswith Psoriatic Arthritis. Erciyes Medical Journal 43, no.1 (2021): 20 - 25. 10.14744/etd.2020.65625
MLA Icen Taskin Irmak,İRTEGÜN KANDEMİR Sevgi,NAS Kemal,Dağlı Abdullah Zübeyir Serum Level of ADAMTS4 and ADAMTS8 in Patientswith Psoriatic Arthritis. Erciyes Medical Journal, vol.43, no.1, 2021, ss.20 - 25. 10.14744/etd.2020.65625
AMA Icen Taskin I,İRTEGÜN KANDEMİR S,NAS K,Dağlı A Serum Level of ADAMTS4 and ADAMTS8 in Patientswith Psoriatic Arthritis. Erciyes Medical Journal. 2021; 43(1): 20 - 25. 10.14744/etd.2020.65625
Vancouver Icen Taskin I,İRTEGÜN KANDEMİR S,NAS K,Dağlı A Serum Level of ADAMTS4 and ADAMTS8 in Patientswith Psoriatic Arthritis. Erciyes Medical Journal. 2021; 43(1): 20 - 25. 10.14744/etd.2020.65625
IEEE Icen Taskin I,İRTEGÜN KANDEMİR S,NAS K,Dağlı A "Serum Level of ADAMTS4 and ADAMTS8 in Patientswith Psoriatic Arthritis." Erciyes Medical Journal, 43, ss.20 - 25, 2021. 10.14744/etd.2020.65625
ISNAD Icen Taskin, Irmak vd. "Serum Level of ADAMTS4 and ADAMTS8 in Patientswith Psoriatic Arthritis". Erciyes Medical Journal 43/1 (2021), 20-25. https://doi.org/10.14744/etd.2020.65625